🇺🇸 FDA
Pipeline program

A Study of LY3200882 in Participants With Solid Tumors.

I8X-MC-JECA

Phase 1 other active

Quick answer

A Study of LY3200882 in Participants With Solid Tumors. for Metastatic cancer, Solid Tumor is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Metastatic cancer, Solid Tumor
Phase
Phase 1
Modality
other
Status
active

Clinical trials